1. Anti-inflammatory and anticancer effects of p-methoxycinnamic acid, an active phenylpropanoid, against 1,2-dimethylhydrazine-induced rat colon carcinogenesis
   Sivagami Gunasekaran et al, 2018, Mol Cell Biochem CrossRef
2. Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer
   Matthew Kearney et al, 2021, Breast Cancer Res Treat CrossRef
3. Combination therapy of calcitriol inhibits the proliferation of breast cancer cells: new concept of nonclassical function of calcitriol
   Khuzama A. Aljunidee et al, 2021 CrossRef
4. Effects of Ruxolitinib and Calcitriol Combination Treatment on Various Molecular Subtypes of Breast Cancer
   Jean Schneider et al, 2022, IJMS CrossRef
5. Visible Light-Promoted Green and Sustainable Approach for One-Pot Synthesis of 4,4’-(Arylmethylene)bis(1H-pyrazol-5-ols), In Vitro Anticancer Activity, and Molecular Docking with Covid-19 Mpro
   Anamika Gupta et al, 2022, ACS Omega CrossRef
6. Combined treatment with ruxolitinib and MK-2206 inhibits the JAK2/STAT5 and PI3K/AKT pathways via apoptosis in MDA-MB-231 breast cancer cell line
   Esin Guvenir Celik et al, 2022, Mol Biol Rep CrossRef
7. Copper-related genes predict prognosis and characteristics of breast cancer
   Yi Liu et al, 2023, Front. Immunol. CrossRef